# Comparison of Real-World Treatment Outcomes With Vedolizumab Versus Infliximab in Biologic-Naive Patients With Inflammatory Bowel Disease

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/comparison-of-real-world-treatment-outcomes-with-vedolizumab-versus-infliximab/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Haridarshan Patel,Dominick Latrémouille-Viau,Rebecca Burne,Sherry Shi,Shashi Adsul |
| Citations | 26 |
| DOI | 10.1093/crocol/otz022 |
| Fields | Biochemistry, Genetics and Molecular Biology,Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://academic.oup.com/crohnscolitis360/article-pdf/1/2/otz022/33029809/otz022.pdf |
| OpenAlex ID | https://openalex.org/W2967486945 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Sherry Shi](https://scholariq.org/researchers/sherry-shi/)

## Paper journal

- [Crohn s & Colitis 360](https://scholariq.org/journals/crohn-s-and-colitis-360/)

## Paper primary topic

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)

## Paper topics

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)
- [Microscopic Colitis](https://scholariq.org/topics/microscopic-colitis/)
- [Biosimilars and Bioanalytical Methods](https://scholariq.org/topics/biosimilars-and-bioanalytical-methods/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.